FATE THERAPEUTICS INC. - COMMON STOCK

NetDania - New 12 months High: FATE THERAPEUTICS INC. - COMMON STOCK

27 2 2024 09:45:16 提供 NetDania Notify

Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates

26 2 2024 16:01:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: FATE THERAPEUTICS INC. - COMMON STOCK

16 2 2024 10:00:35 提供 NetDania Notify

NetDania - New 12 months High: FATE THERAPEUTICS INC. - COMMON STOCK

15 2 2024 10:31:27 提供 NetDania Notify

Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2023 Financial Results

15 2 2024 08:00:00 提供 Nasdaq GlobeNewswire

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

02 2 2024 16:01:00 提供 Nasdaq GlobeNewswire

Fate Therapeutics Announces Initiation of Phase 1 Clinical Trial for FT825 / ONO-8250 in Patients with HER2-expressing Advanced Solid Tumors

08 1 2024 08:00:00 提供 Nasdaq GlobeNewswire

Fate Therapeutics Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

13 12 2023 17:00:00 提供 Nasdaq GlobeNewswire

Fate Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates

08 11 2023 16:01:00 提供 Nasdaq GlobeNewswire

Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2023 Financial Results

25 10 2023 08:00:01 提供 Nasdaq GlobeNewswire

Fate Therapeutics to Present at Upcoming September Investor Conferences

31 8 2023 08:00:00 提供 Nasdaq GlobeNewswire

Fate Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates

08 8 2023 16:01:00 提供 Nasdaq GlobeNewswire

Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2023 Financial Results

28 7 2023 08:00:00 提供 Nasdaq GlobeNewswire

Fate Therapeutics to Present at Upcoming June Investor Conferences

31 5 2023 08:00:01 提供 Nasdaq GlobeNewswire

Fate Therapeutics Reports First Quarter 2023 Financial Results and Business Updates

03 5 2023 16:01:00 提供 Nasdaq GlobeNewswire

Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2023 Financial Results

24 4 2023 08:00:00 提供 Nasdaq GlobeNewswire

Fate Therapeutics to Present at Upcoming March Investor Conferences

03 3 2023 16:01:00 提供 Nasdaq GlobeNewswire

Fate Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates

28 2 2023 16:01:00 提供 Nasdaq GlobeNewswire

Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2022 Financial Results

13 2 2023 08:00:00 提供 Nasdaq GlobeNewswire

Fate Therapeutics Announces Termination of Collaboration Agreement with Janssen, Pipeline Prioritization, Next-Generation Programs, and Key 2023 Initiatives

05 1 2023 17:00:00 提供 Nasdaq GlobeNewswire